Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
BACKGROUND: Cystic fibrosis is a multi-system disease characterised by the production of thick secretions causing recurrent pulmonary infection, often with unusual bacteria. Intravenous antibiotics are commonly used in the treatment of acute deteriorations in symptoms (pulmonary exacerbations); howe...
| Main Authors: | Hurley, M., Prayle, A.P., Flume, P. |
|---|---|
| Format: | Article |
| Published: |
Wiley
2015
|
| Online Access: | https://eprints.nottingham.ac.uk/49717/ |
Similar Items
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)
by: Prayle, A.P., et al.
Published: (2015)
Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)
by: Hurley, M.N., et al.
Published: (2011)
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis
by: Barr, Helen L., et al.
Published: (2017)
by: Barr, Helen L., et al.
Published: (2017)
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)
by: Langton Hewer, Simon C., et al.
Published: (2014)
Who benefits when parents administer intravenous antibiotics, at home, to children with cystic fibrosis? A critical review.
by: Walsh, Daniel
Published: (2009)
by: Walsh, Daniel
Published: (2009)
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Once-daily versus multiple-daily dosing with intravenous
aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Association of Antibiotics, Airway Microbiome and Inflammation in Infants with Cystic Fibrosis.
by: Pittman, J., et al.
Published: (2017)
by: Pittman, J., et al.
Published: (2017)
Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)
by: Liu, Yi-Chia
Published: (2014)
Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection
by: Simpson, S., et al.
Published: (2015)
by: Simpson, S., et al.
Published: (2015)
Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)
by: Hurley, Matthew, et al.
Published: (2017)
US Cystic Fibrosis Foundation and European Cystic
Fibrosis Society consensus recommendations for the
management of non-tuberculous mycobacteria
in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)
by: Floto, R. Andres, et al.
Published: (2016)
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial
by: Lee, A., et al.
Published: (2010)
by: Lee, A., et al.
Published: (2010)
Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)
by: Subbarao, P., et al.
Published: (2015)
Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)
by: Webb, Karmel
Published: (2022)
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Optimising Assessment and Rehabilitation in People Hospitalised with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Mirza Mohd Tahir Beg, Fatim Tahirah
Published: (2016)
by: Mirza Mohd Tahir Beg, Fatim Tahirah
Published: (2016)
Interventions for the eradication of meticillin-resistant
Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)
by: Smyth, Alan R.
Published: (2015)
Field Walking Tests Are Reliable and Responsive to Exercise Training in People With Non–Cystic Fibrosis Bronchiectasis
by: Lee, A., et al.
Published: (2015)
by: Lee, A., et al.
Published: (2015)
Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)
by: Maxwell, Susannah, et al.
Published: (2011)
European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Research Protocol - Effect of anti-staphylococcal antibiotic prophylaxis upon isolation and colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and their resistant variants in cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2016)
by: Hurley, Matthew, et al.
Published: (2016)
METABOLOMIC RESPONSE OF HEALTHY AND CYSTIC FIBROSIS EPITHELIUM TO RHINOVIRUS
by: Agudelo-Romero, P., et al.
Published: (2019)
by: Agudelo-Romero, P., et al.
Published: (2019)
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)
by: Thomson, E., et al.
Published: (2010)
Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)
by: Waters, Valerie, et al.
Published: (2015)
Infection, inflammation,and lung function decline in infants with cystic fibrosis
by: Pillarisetti, N., et al.
Published: (2011)
by: Pillarisetti, N., et al.
Published: (2011)
Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
by: Dalleywater, William, et al.
Published: (2014)
by: Dalleywater, William, et al.
Published: (2014)
Respiratory viral infections in Western Australians with cystic fibrosis
by: Brestovac, Brian, et al.
Published: (2020)
by: Brestovac, Brian, et al.
Published: (2020)
Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)
by: Norman, Richard, et al.
Published: (2012)
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017)
by: Rowbotham, Nicola J., et al.
Published: (2017)
POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)
by: Laucirica, D.R., et al.
Published: (2019)
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis
by: Ramsey, K., et al.
Published: (2014)
by: Ramsey, K., et al.
Published: (2014)
Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)
by: Jain, Kamini
Published: (2018)
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)
by: Palser, Sally C.
Published: (2024)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)
by: Gini, A., et al.
Published: (2018)
Pancreatic cystosis: A rare pancreatic manifestation
in cystic fibrosis
by: Mohammad A. Wazzan,
Published: (2015)
by: Mohammad A. Wazzan,
Published: (2015)
Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)
by: Holmes, H., et al.
Published: (2013)
Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)
by: Habgood, Anthony
Published: (2018)
Similar Items
-
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015) -
Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011) -
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis
by: Barr, Helen L., et al.
Published: (2017) -
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014) -
Who benefits when parents administer intravenous antibiotics, at home, to children with cystic fibrosis? A critical review.
by: Walsh, Daniel
Published: (2009)